Genmab-partner tjener mere end ventet trods fald i omsætning

Det schweiziske medicinalselskab Novartis, der har salgsrettighederne til Genmabs kræftmiddel Arzerra, tjente flere penge end ventet i sit andet kvartal. I regnskabet for andet kvartal, …

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and